CME Info
2026 ASCCP Scientific Meeting on Anogenital and HPV-Related Diseases
Through an array of educational offerings, the 2026 ASCCP Scientific Meeting on Anogenital and HPV-Related Diseases will bring together healthcare professionals from different backgrounds and experience levels who are interested in staying informed about the latest research dedicated to improving clinical outcomes and to reducing the burden of anogenital and HPV-related diseases around the world.
Educational Objectives:
- Integrate into practice new insights from the latest research on prevention, diagnosis and management of anogenital and HPV-related diseases.
- Describe the biology, epidemiology, natural history, and immune response to HPV, as well as the societal costs associated with HPV infections.
- Apply consensus guidelines for cervical cancer screening and management of cervical abnormalities to the general population as well as those in special circumstances.
- Apply novel screening and management strategies to underserved and under-screened individuals (transgender, incarcerated, etc.).
- Apply colposcopy to the diagnosis and management of anogenital and HPV-related diseases in ways that reflect its usefulness and maximum benefits while minimizing potential harms.
- Diagnose and treat HPV-related diseases including those that affect the cervix, vagina, vulva, anus, and head/neck. .
- Identify strategies for prevention and screening of HPV-associated oropharyngeal disorders.
- Identify novel and experimental uses of therapeutic and prophylactic HPV vaccines, including the use of “catch-up” HPV immunization.
- Apply HPV testing and relevant diagnostic tests to clinical practice in a directed, evidence-based, cost-effective manner.
- Describe the vaginal microbiome and describe its impact on HPV clearance.
- Recognize the impact of implicit bias on patient care and learn techniques to identify and address this bias.
- Apply data on HPV ecology to screening and management of patients who are postmenopausal.
- Manage positive cytology and HPV test results, high risk HPV genotype results, and histologically confirmed anogenital neoplasia, reflecting current and future patient risk of high grade neoplasia.
Continuing Medical Education (CME)
ACCME Accreditation Statement
The ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The American Society for Colposcopy and Cervical Pathology (ASCCP) designates this Other Activity (Live and Enduring Material) for up to 26 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ASCCP any financial relationship(s) that have occurred within the prior 24 months with any ineligible companies. Financial relationships are defined as remuneration in any amount from ineligible companies in the form of grants, research support, consulting fees, salary, ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds), honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors, or other financial benefits. The intent of this disclosure is not to prevent individuals with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ASCCP has reviewed all disclosures and mitigated all relevant financial relationships that have been identified.
Attend ASCCP Scientific Meeting In-Person
Don’t miss an immersive experience with insightful presentations and engaging discussions.
The following person(s) disclosed relevant financial relationships:
| Program Directors/Planners | Content Reviewers | Faculty | Relevant Financial Relationship |
|---|---|---|---|
| Marcela Celis Amortegui, MD, MPH | Merck (Speaker) | ||
| Christine Conageski, MD, MSc | Christine Conageski, MD, MSc | Merck (Advisory Board) | |
| Mark Einstein, MD | Antiva (Consultant), Merck (Consultant), Papivax (Consultant), PDS Biotechnologies (Consultant), LinKinVax (Consultant), Aserls Pharmaceuticals (Consultant) | ||
| Richard Guido, MD | Pinion Immunotherapeutics (Consultant) | ||
| Hope Haefner, MD | Author on UptoDate (Royalties or Patent Beneficiary) | ||
| Megan Huchko, MD, MPH | Merck (Consultant) | ||
| Michelle Khan, MD, MPH, FACOG | Medicines 360 (research funds received by my institution), Histologics (received donated devices for a research study) | ||
| Jenna Marcus, MD | Jenna Marcus, MD | Pfizer (Speaker’s Bureau), GSK (Speaker’s Bureau), Intuitive (Consultant) | |
| Amber Naresh, MD | Amber Naresh, MD | Merck (Grant Recipient) | |
| Alfonso Quesada, MD | Procare Health (Principal Investigator) | ||
| Lisa Rahangdale, MD, MPH | Antiva (Safety Monitoring panel Last financial payment was Jan 2025) | ||
| Sangini Sheth, MD, MPH | Merck (Consultant) | ||
| Sveinung Werfeland Sorbye, MD, PHD | PreTect AS (Consultant) |
All relevant financial relationships listed for these individuals have been mitigated.
The following person(s) disclosed no financial relationships:
| Program Directors/Planners | Content Reviewers | Faculty | Staff |
|---|---|---|---|
| Lisa R. Gabor, MD | Swati Bhardwaj, MD | Prajakta Adsul, MBBS, MPH, PhD | Cassidy Brown |
| Lindsay Kuroki, MD, MSCI | Jennifer Brown, FNP | Carmen Álvarez Gil, MD | Diane Catalano |
| Helen Cejtin, MD, MPH | Maria Anisimova | Kerry Curtis | |
| Rebekah Compton, DNP, FNP-BC, MBA | Brian Befano, MPH PhD(c) | Connor Hendrix | |
| Stacia Crochet, MD | Bethany Berry, CNM | Jenn Natale | |
| Sarah Diemert, WHNP | Mario R. Castellanos, MD | Robert Pulley | |
| Victor Feldbaum, MD | Philip Castle, PhD, MPH | Joe Pymm | |
| Laura Fry, MD | Liuyan Chen, MBBS | Nicole Ratner | |
| Kimberly Gecsi, MD | Rebekah Compton, DNP, FNP-BC, MBA | Liesl Robinson | |
| June Gupta, NP | Qing Cong, MD, PhD | ||
| Xuezhi (Daniel) Jiang, MD, PHD, MSCP | Tri A. Dinh, MD | ||
| Rochelle Joly, MD | Didem Egemen, PhD | ||
| Kelsey Kelso, MD | Frederick Eruo, MD, MPH | ||
| Kristin Kepler, DNP, WHNP-BC, FNP | Maria E. Fernandez, PhD | ||
| Elizabeth A. Kostas-Polston, PHD, WHNP, APRN | Lisa R. Gabor, MD | ||
| Ghiara Lugo, MD | Francisco Garcia, MD, MPH, FACOG | ||
| Erin Nelson, MD | Professor Omar Gassama | ||
| Esteban Ortega, MD, MPH | Jessie Hillingsworth, MD | ||
| Susan Park, MD, MPH | Patricia Jeudin, MD | ||
| Kelsey Schmidt, MD | Xuezhi (Daniel) Jiang, MD, PhD, MSCP | ||
| Marian Yvette William-Brown, MD | Paul Kamfwa, MD | ||
| Nadi Nina Kaonga, MD, MHS, MS, FACOG | |||
| Elizabeth A. Kostas-Polston, PHD, WHNP, APRN | |||
| Lindsay Kuroki, MD, MSCI | |||
| Mingzhu Li, MD, PhD | |||
| Quanlong Lu, MDc | |||
| L. Steward Massad, MD | |||
| E.J. Mayeaux Jr., MD, DABFM, FAAFP, DABPM-CI | |||
| Jane R. Montealegre, PhD MSPH | |||
| Giacomo Nebbia, PhD | |||
| Hanfei Niu, MD, PhDc | |||
| Michael Nosal, MASc | |||
| Akiva Novetsky, MD, MS | |||
| Dung Nguyen, MD | |||
| Idyoro Ojukwu, MD | |||
| Ngoc TH Phan, MD | |||
| Maria Pimenova MD | |||
| Xuan Rao, PhD | |||
| Mark Schiffman, MD | |||
| Peter F. Schnatz, DO, MBA | |||
| Joanne Sheu, MD, MPH | |||
| Riddhimaa Sinha, MS | |||
| Dianelle Soto, MD | |||
| Elizabeth Stier, MD | |||
| Colleen Stockdale, MD, MS | |||
| Long Sui, MD, PhD | |||
| Pengming Sun, MD, PhD | |||
| Mary Grace Tadros, MD | |||
| Quynh N Tran, MD | |||
| Susan T. Vadaparampil, PhD, MPH | |||
| Trang NX Vo, MD | |||
| Alan G. Waxman, MD, MPH | |||
| Kathryn Welch, MD | |||
| Amy Wiser, MD | |||
| Peng Xue, PhD | |||
| Chengquan Zhao, MD | |||
| Yun Zhao, MD, PhD |